Objective To synthetical analyse the current status of medication in portal hypertension (PHT) and the direction of development. Methods Papers of treatment of PHT in large quantity of cases and /or by standard clinical test were collected and reviewed. Results Treatment of PHT had been converted from surgery to medication gradually.The effect of medication had increased gradually with drug improvement.Conclusions Medication of portal hypertention is an effective and practicable technique to treat portal hypertention, and it is the research direction in the future.

Intravenous glucose tolerance test(IVGTT)and oral glucose-insulin releasing test(OGIRT) in 12 subjects with normal glucose tolerance were performed.The results showed that the peak of insulin secretion Was at 40 minutes during()GIRT.The ratio of the change of insulin-to-glucose at 40 minutes(△I40/△G40)is an index in reflecting insulin sensitivity and β-cell function.

[Summary] The high-risk subjects of type 2 diabetes mellitus ( T2DM) in normal glucose tolerance ( NGT) were screened. The subjects with NGT at baseline were divided into high-risk and low-risk groups according to the diagnostic threshold of insulin area under the curve ( AUCINS ) 108. 43 mU/L. The incidence of prediabetes and/or T2DM was significantly increased in high risk group in comparison with low risk group ( 29. 41 vs 2. 21%, P<0. 01). The result suggests that the diagnosis threshold for AUCINS≥108. 43 mU/L can be used to screen the high-risk subjects of T2DM in NGT.